论文部分内容阅读
广州医学院药理学教研组与上海生物制品研究所协作试制成功的我国首批精制银环蛇抗毒素于1976年7月在广东省卫生局领导下,正式开始临床试用,首先以广东省佛山地区及广州市五县一郊为重点,安排了三十九个协作临床试用点进行工作。今年2月28日,我们初次报道了使用本抗毒素救治七例银环蛇咬伤病人的疗效观察。现将新增加的十一例银环蛇伤病人(危重型4例;重型6例;轻型1例)使用本抗毒素救治的临床效果,简报如下:
Pharmacology teaching and research team of Guangzhou Medical College and Shanghai Institute of Biological Products pilot trial success of China’s first batch of refined silver snake antitoxin in July 1976 under the leadership of the Guangdong Provincial Health Bureau, officially began clinical trials, first of all to Foshan, Guangdong Province and Guangzhou City five suburbs as the focus, arranged for 39 collaborative clinical trial point to work. February 28 this year, we first reported the use of this antitoxin treatment of biliary snake bites in seven patients observed. The clinical efficacy of this antitoxin treatment is now summarized in the following new eleven cases of silver snakebolt patients (4 in critical and 6 in severe; 1 in light)